Cinven has promoted three staffers to partner and another to director. The new partners are Chris Good, Thomas Railhac and Ivan Kwok. And, Brett Lewis has become a director on the portfolio team.
International private equity firm Cinven today announces the promotion of three individuals to Partner, along with one promotion to Director.
Chris Good, Partner
Chris is a member of the TMT sector team and the UK and Ireland regional team. He has been involved in a number of investments, including Amadeus, CPA Global, Hotelbeds, Northgate Public Services, Springer and Visma. He joined Cinven in 2006.
Thomas Railhac, Partner
Thomas is a member of the TMT sector team and the regional team for France. He has been involved in a number of transactions, including Allegro, HEG, Numericable Group and Ufinet. He joined Cinven in 2008.
Ivan Kwok, Partner, Portfolio Team
Ivan is a member of the Portfolio team and is responsible for the internationalisation strategy for Cinven’s portfolio companies. He has been involved with Cinven portfolio companies including Gondola, SLV, AMCo, Kurt Geiger and Bioclinica. He joined Cinven in 2010.
In addition, Brett Lewis has been promoted to Director in the Portfolio team.
Brett Lewis, Director, Portfolio Team
Brett is a member of the Portfolio team in New York. He joined Cinven in 2015.
Commenting on these appointments, Stuart McAlpine, Managing Partner of Cinven Partners LLP, said:
“These promotions reflect the significant contribution these individuals have made to our business, as well as their considerable hard work. They also reflect our focus on continuing to hire and invest in a highly talented Investment team.
“2016 has been a strong year for Cinven and we start 2017 well positioned to capitalise on the numerous investment and realisation opportunities throughout the year.”
Take your pick!
- Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
- VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.